BACKGROUND
In 1930, the German pathologist Karl Fahr reported on an adult case of idiopathic and extensive calcification of the basal ganglia (1) . Although bilateral and diffuse cerebral calcification was noted long before the publication of Fahr's paper, but his name has been attached to this observation since then (2) . Actually, his contribution added little to the knowledge of this condition. In Fahr's disease, calcium deposition occurs bilaterally and symmetrically in the basal ganglia, thalami, deep cerebellar nuclei, and white matter of the cerebral hemispheres and most cases present with abnormal movements and Parkinsonism. Seizures, sub-cortical dementia, and cerebellar dysfunction may be additional features in some patients.
CASE PRESENTATION
A 25-year-old single woman was brought to our neurology outpatients' clinic by her parents. The family stated that the patient had been experiencing impairment in memory, irritability, poor night time sleep, and social isolation over the past 6 years, a constellation that points In addition to displaying an early onset of Fahr's disease, the cognitive decline (without abnormal movements and seizures) and apathy dominated the clinical picture in our patient. Although the patient had generalized rigidity, no tremor (of any type) was found.
The cognitive decline is consistent with a subcortical type of dementia. This type of dementia is characterized by marked psychosocial incompetence (and minimal memory loss) in the absence of aphasia, agnosia, and apraxia (11) . Most patients display a variable combination of forgetfulness, slowing of thought processes, mild intellectual impairment, irritability, depression, apathy, and inability to manipulate knowledge; a picture which resembles frontal lobe dysfunction (12) . The memory impairment is highlighted by a prominent deficit of spontaneous recall, rather than problems of encoding and storage of new materials, which is characteristic of the cortical dementias (13) . For example, as stated above, patients may be entirely asymptomatic regardless of the degree of calcification (8, 9) . On the other hand, some patients may develop the fully-fledged Fahr's disease while displaying "minimal" intra-cerebral calcification (15) .
We screened the rest of her family (parents and siblings) using non-contrast CT brain scanning; none of them had any form of intracranial calcification. Their ages ranged from 21 years (the youngest sibling) to 56 years (her father). It should be noted that the minimum age at which "negative" CT brain scanning can exclude the disease has not been established yet (16) . Genetic testing is not available in Iraq, although the precise role of this investigation is still vague (17) .
The parents were educated about the course of the disease and its prognosis and that there is no cure. During the follow-up period of 1 and a half year, the patient had not developed seizures and her cognitive deficits were more or less the same. During the same period, we prescribed alprazolam 0.5 mg to improve her insomnia while her behavioral and cognitive functions were more or less the same on rivastgimine 3 mg/day and sertraline 100 mg/day.
LIMITATIONS
1. The period of follow-up covered a year and a half.
The outcome might well have been different if this period of observation was longer.
2. Oral alprazolam was used for short courses, 2-weeks maximum in our patient, to help with insomnia, although the pertinent literature does not support this approach.
3. Rivastigmine, 3 mg per day, was used for the cognitive dysfunction, which seemed to be plateaued on this medication. Other central acetylcholinesterase inhibitors were not tried.
